Montelukast combined fluticasone infants and young children with acute asthma attack prevention.doc

 PAGE \* MERGEFORMAT 7 Montelukast combined fluticasone infants and young children with acute asthma attack prevention OF: ZHANG Wen-juan, Zhouzheng Bing, Zhang Kaijun, high-Lulu [Abstract] Objective To observe the Chameng Lu Sterling combined fluticasone prevention of infant asthma clinical efficacy. Methods randomized method, 72 cases of children with asthma were divided into 2 groups: treatment group 36 patients given fluticasone inhalation, and oral montelukast Special; control group, 36 cases only inhaled fluticasone, once every 6 months. Results The treatment group of the clinical efficacy than the control group, the difference was statistically significant (P lt;0.01). Conclusion Montelukast combined inhaled fluticasone than a single inhalation of fluticasone efficacy, and can reduce the recurrence rate. [Keywords:] Asthma; montelukast; fluticasone; infants and young children [Abstract] Objective To investigate the therapeutic effect of the combined administration of montelukast and inhaled fluticasone on asthmatic infant.Methods 72 cases were randomly divided into two groups.The control group of 36 cases were treated with inhaled fluticasone and the therapy group of 36 cases with the combination of montelukast and inhaled fluticasone.The duration of treatment was 6 months.Results The therapy group was better than the control group (P lt;0.01). Conclusion The combination of montelukast and inhaled fluticasone is more effective than mere inhaled fluticasone, and it can reduce the rate of recurrence as well. [Key word] Asthma; Montelukast; Fluticasone; Infant Bronchial asthma is the most common childhood chronic inflammatory airway diseases. In recent years, its prevalence rate increased year by year and age of onset of increasingly younger age. Inhaled corticosteroids is the world’s first-line treatment of asthma drugs, but with asthma depth study of the pathogenesis, and gradually realize that leukotrienes in asthma pathogenesis an impo